Showing results (71-80 of 81) with videos related to
Sort By:
Pageof 9
The American Journal of Gastroenterology|February 2, 2023
A Prospective Study of Preemptive Tenofovir Disoproxil Fumarate Therapy in HBsAg-Positive Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and PrednisoneDo Young Kim, Yu Ri Kim, Cheolwon Suh, et al.International Journal of Hematology|September 5, 2020
Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasoneHo Sup Lee, Kihyun Kim, Je-Jung Lee, et al.Annals of Hematology|December 25, 2019
The effectiveness and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma in real-world clinical practice: a study of the Korean Multiple Myeloma Working Party (KMMWP-151 study)Jae-Cheol Jo, Ho Sup Lee, Kihyun Kim, et al.Blood Cancer Journal|June 26, 2023
Real-world data of long-term survival in patients with T-cell lymphoma who underwent stem cell transplantationDong Won Baek, Joon Ho Moon, Jae Hoon Lee, et al.Frontiers in Oncology|September 7, 2023
Comparison of first-line treatment with CHOP versus ICED in patients with peripheral T-cell lymphoma eligible for upfront autologous stem cell transplantationSeok Jin Kim, Jae-Cheol Jo, Dok Hyun Yoon, et al.American Journal of Hematology|August 1, 2015
Long-term follow-up of imatinib plus combination chemotherapy in patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemiaSung-Nam Lim, Young-Don Joo, Kyoo-Hyung Lee, et al.Blood Research|June 9, 2022
Safety and efficacy of nilotinib in adult patients with chronic myeloid leukemia: a post-marketing surveillance study in KoreaSeo-Yeon Ahn, Sang Kyun Son, Gyu Hyung Lee, et al.Blood|June 13, 2015
Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemiaDae-Young Kim, Young-Don Joo, Sung-Nam Lim, et al.Blood Research|February 4, 2025
Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questionsSung-Hoon Jung, Youngil Koh, Min Kyoung Kim, et al.Acta Haematologica|September 26, 2018
The Derived Neutrophil-to-Lymphocyte Ratio Is an Independent Prognostic Factor in Transplantation Ineligible Patients with Multiple MyelomaGyeong-Won Lee, Sung Woo Park, Se-Il Go, et al.Pageof 9